tiprankstipranks
Arrowhead Pharmaceuticals (GB:0HI3)
LSE:0HI3
Holding GB:0HI3?
Track your performance easily

Arrowhead Pharmaceuticals (0HI3) Financial Statements

0 Followers

Arrowhead Pharmaceuticals Financial Overview

Arrowhead Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.999; its P/E ratio is -3.84; Arrowhead Pharmaceuticals is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue---$ 3.55M$ 16.10M
Gross Profit---$ 3.55M$ 16.10M
EBIT$ -177.89M$ -168.88M$ -119.75M$ -133.32M$ -103.73M
EBITDA$ -172.87M$ -164.10M$ -115.23M$ -129.06M$ -99.87M
Net Income Common Stockholders$ -175.62M$ -165.70M$ -125.30M$ -132.88M$ -109.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 578.28M$ 367.27M$ 395.41M$ 162.06M$ 292.74M
Total Assets$ 1.14B$ 883.76M$ 955.15M$ 626.29M$ 765.55M
Total Debt$ 510.55M$ 118.09M$ 118.92M$ 118.58M$ 115.17M
Net Debt$ -67.72M$ -249.18M$ -276.49M$ -43.49M$ -177.56M
Total Liabilities$ 948.74M$ 544.78M$ 459.75M$ 452.57M$ 478.39M
Stockholders Equity$ 185.44M$ 330.55M$ 483.79M$ 160.41M$ 271.34M
Cash Flow-
Free Cash Flow$ -161.50M$ -129.87M$ -126.45M$ -186.50M$ -89.16M
Operating Cash Flow$ -137.22M$ -115.42M$ -92.38M$ -117.84M$ -25.26M
Investing Cash Flow$ -222.92M$ 6.95M$ -268.94M$ 64.84M$ 30.51M
Financing Cash Flow$ 389.09M$ 50.39M$ 430.78M$ 267.00K$ 152.00K
Currency in USD

Arrowhead Pharmaceuticals Earnings and Revenue History

Arrowhead Pharmaceuticals Debt to Assets

Arrowhead Pharmaceuticals Cash Flow

Arrowhead Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis